Soverini, S.; Castagnetti, F., How I evaluate and treat resistance and relapse in CML, «BLOOD», 2026, 147, pp. 337 - 346 [Scientific article]
Castagnetti, F.; Breccia, M.; Abruzzese, E.; Bassan, R.; Binotto, G.; Bonifacio, M.; Caocci, G.; Capodanno, I.; Cavazzini, F.; Cimino, G.; Fazi, P.; Gozzini, A.; Iurlo, A.; Janssen, J. J. W. M.; Lunghi, M.; Marasca, R.; Martino, B.; Messina, M.; Muriano, F.; Paoloni, F.; Piciocchi, A.; Rosti, G.; Russo Rossi, A.; Saglio, G.; Sica, S.; Soverini, S.; Tafuri, A.; Vallisa, D.; Westerweel, P. E.; Pane, F., Nilotinib versus imatinib with early switch from imatinib to nilotinib to obtain treatment-free remission in newly diagnosed chronic myeloid leukemia patients: the analysis of the first co-primary endpoint, «LEUKEMIA», 2026, 40, pp. 47 - 54 [Scientific article]
Breccia, M.; Cucci, R.; Marsili, G.; Castagnetti, F.; Galimberti, S.; Izzo, B.; Sorà, F.; Soverini, S.; Messina, M.; Piciocchi, A.; Bonifacio, M.; Cilloni, D.; Iurlo, A.; Martinelli, G.; Rosti, G.; Stagno, F.; Fazi, P.; Vignetti, M.; Pane, F., Deep Molecular Response Rate in Chronic Phase Chronic Myeloid Leukemia: Eligibility to Discontinuation Related to Time to Response and Different Frontline TKI in the Experience of the Gimema Labnet CML National Network, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2025, 25, pp. 34 - 39 [Scientific article]
Stagno, F.; Cucci, R.; Marsili, G.; Castagnetti, F.; Galimberti, S.; Izzo, B.; Sorà, F.; Soverini, S.; Messina, M.; Piciocchi, A.; Bonifacio, M.; Cilloni, D.; Iurlo, A.; Martinelli, G.; Rosti, G.; Fazi, P.; Vignetti, M.; Breccia, M.; Allegra, A.; Pane, F., Outcome of Chronic Myeloid Leukemia Patients Not in Deep Molecular Response: Results From the GIMEMA LabNet CML Network Database, «AMERICAN JOURNAL OF HEMATOLOGY», 2025, 100, pp. 1467 - 1470 [Scientific article]
Mancini, Manuela; De Santis, Sara; Monaldi, Cecilia; Castagnetti, Fausto; Iezza, Miriam; Iurlo, Alessandra; Cattaneo, Daniele; Galimberti, Sara; Cerrano, Marco; Capodanno, Isabella; Bonifacio, Massimiliano; Rossi, Maura; Agostinelli, Claudio; Meggendorfer, Manja; Haferlach, Torsten; Cavo, Michele; Gugliotta, Gabriele; Soverini, Simona, SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability, «CLINICAL AND TRANSLATIONAL MEDICINE», 2025, 15, pp. 70163 - 70177 [Scientific article]
Apperley, Jf; Milojkovic, D; Cross, Ncp; Hjorth-Hansen, H; Hochhaus, A; Kantarjian, H; Lipton, Jh; Malhotra, H; Niederwieser, D; Radich, J; Rousselot, P; Saussele, S; Schiffer, Ca; Silver, R; Soverini, S; Stenke, L; Turkina, A; Casado, Lf; Castagnetti, F; Cervantes, F; Clark, Re; Cortes, J; Deininger, M; Hughes, Tp; Janssen, J; Jiang, Q; Kim, Dw; Larson, Ra; Mahon, Fx; Mauro, M; Mayer, J; Nicolini, Fe; Pane, F; Rea, D; Richter, J; Rosti, G; Saglio, G; Hehlmann, R, 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia, «LEUKEMIA», 2025, 39, pp. 1797 - 1813 [Scientific article]
Sciumè, Mariarita; Serpenti, Fabio; Zanotti, Roberta; Bonadonna, Patrizia; Tanasi, Ilaria; Crosera, Lara; Elena, Chiara; Mannelli, Francesco; Crupi, Francesca; Papayannidis, Cristina; Sartor, Chiara; Soverini, Simona; Rondoni, Michela; Eller‐Vainicher, Cristina; Pravettoni, Valerio; Rivolta, Federica; Alberti Violetti, Silvia; Croci, Giorgio Alberto; Migliorini, Anna Chiara; Bolli, Niccolò; Giannarelli, Diana; Grifoni, Federica Irene, Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis, «HEMATOLOGICAL ONCOLOGY», 2024, 42, pp. N/A - N/A [Scientific article]
Forte, D.; Pellegrino, R. M.; Falvo, P.; Garcia-Gonzalez, P.; Alabed, H. B. R.; Maltoni, F.; Lombardi, D.; Bruno, S.; Barone, M.; Pasini, F.; Fabbri, F.; Vannini, I.; Donati, B.; Cristiano, G.; Sartor, C.; Ronzoni, S.; Ciarrocchi, A.; Buratta, S.; Urbanelli, L.; Emiliani, C.; Soverini, S.; Catani, L.; Bertolini, F.; Argüello, R. J.; Cavo, M.; Curti, A., Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia, «NATURE COMMUNICATIONS», 2024, 15, Article number: 10878 , pp. 1 - 19 [Scientific article]Open Access
Bruno, S.; Borsi, E.; Patuelli, A.; Bandini, L.; Mancini, M.; Forte, D.; Nanni, J.; Barone, M.; Grassi, A.; Cristiano, G.; Venturi, C.; Robustelli, V.; Atzeni, G.; Mosca, C.; De Santis, S.; Monaldi, C.; Poletti, A.; Terragna, C.; Curti, A.; Cavo, M.; Soverini, S.; Ottaviani, E., Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2024, 25, Article number: 10002 , pp. 1 - 15 [Scientific article]Open Access
Benesova, A.; De Santis, S.; Polivkova, V.; Pecherkova, P.; Krizkova, J.; Suchankova, P.; Monaldi, C.; Klamova, H.; Srbova, D.; Zizkova, H.; Hochhaus, A.; Soverini, S.; Machova Polakova, K., Unstable major molecular response as a trigger for next generation sequencing-based BCR::ABL1 mutation testing in chronic myeloid leukemia, «AMERICAN JOURNAL OF HEMATOLOGY», 2024, 99, pp. 759 - 762 [Scientific article]
Cross N.C.P.; Ernst T.; Branford S.; Cayuela J.-M.; Deininger M.; Fabarius A.; Kim D.D.H.; Machova Polakova K.; Radich J.P.; Hehlmann R.; Hochhaus A.; Apperley J.F.; Soverini S., European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia, «LEUKEMIA», 2023, 37, pp. 2150 - 2167 [Scientific article]Open Access
Iezza M.; Cortesi S.; Ottaviani E.; Mancini M.; Venturi C.; Monaldi C.; De Santis S.; Testoni N.; Soverini S.; Rosti G.; Cavo M.; Castagnetti F., Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights, «CELLS», 2023, 12, Article number: 1703 , pp. 1703 - 1727 [Scientific article]Open Access
Soverini S., Resistance mutations in CML and how we approach them, in: Hematology, ASH Education Program, 2023, 2023, pp. 469 - 475 (atti di: 65th ASH Annual Meeting, San Diego, 9-12/12/2023) [Contribution to conference proceedings]
Mancini M.; Monaldi C.; De Santis S.; Papayannidis C.; Rondoni M.; Sartor C.; Bruno S.; Pagano L.; Criscuolo M.; Zanotti R.; Bonifacio M.; Tosi P.; Arock M.; Valent P.; Cavo M.; Soverini S., SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted, «BIOMARKER RESEARCH», 2023, 11, Article number: 29 , pp. 29 - 41 [Scientific article]Open Access
Forte, D; Maltoni, F; Bruno, S; Garcia-Gonzalez, P; Cristiano, G; Sartor, C; Soverini, S; Catani, L; Argüello, Rj; Cavo, M; Curti, A, Single-Cell Metabolic Profiling Integrated with Extracellular Vesicle Analysis Reveals Novel Metabolic Vulnerabilities and Prognostic Biomarkers in Acute Myeloid Leukemia, in: Blood, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, ELSEVIER, «BLOOD», 2023, 142, pp. 1598 - 1598 (atti di: American Society of Hematology (ASH) Annual Meeting, San Diego, 12/2023) [Contribution to conference proceedings]
